drugset / Trial / NCT01554046

The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

NCT01554046

Completed 40 enrolled Sheba Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the familial response to Methylphenidate treatment (Ritalin IR) in two aspects: ADHD symptom's improvement and side-effects development.

Timeline

Start
2011-10
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 35 mg
Subject Methylphenidate Small molecule 50 mg
Subject Methylphenidate Small molecule 80 mg